do-me/EUR-LEX huggingface dataset:
Case T-278/23: Judgment of the General Court of 24 September 2025 – Zentiva and Zentiva Pharma v Commission (Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505821EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5821


10.11.2025






Judgment of the General Court of 24 September 2025 – Zentiva and Zentiva Pharma v Commission


(Case T-278/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation for Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5821)
Language of the case: English

Parties


Applicants: Zentiva k.s. (Prague, Czech Republic), Zentiva Pharma GmbH (Frankfurt am Main, Germany) (represented by: K. Roox, T. De Meese, J. Stuyck and C. Dumont, lawyers)

Defendant: European Commission (represented by: L Haasbeek, E. Mathieu and A. Spina, acting as Agents)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Re:

By their action under Article 263 TFEU, the applicants seek the annulment of Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use;










2.


Dismisses the action as to the remainder;










3.


Orders the European Commission, in addition to bearing its own costs, to pay the costs incurred by Zentiva k.s. and by Zentiva Pharma GmbH, including those relating to the interim proceedings before the Court;










4.


Declares that Biogen Netherlands BV is to bear its own costs.






(1)  
            OJ C 252, 17.7.2023.


ELI: http://data.europa.eu/eli/C/2025/5821/oj
ISSN 1977-091X (electronic edition)
Case T-552/24: Judgment of the General Court of 24 September 2025 – Lami v Frontex (Civil service – Contract staff – Frontex staff – Annual leave – Articles 56a and 57 of the Staff Regulations – Shift work – Deduction of days of leave – Equal treatment)
Date: 2025-09-24
Institutions: General Court
Subjects: contract staff, equal treatment, paid leave, servant (EU), shift work, staff regulations (EU)








C_202505843EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5843


10.11.2025






Judgment of the General Court of 24 September 2025 – Lami v Frontex


(Case T-552/24)
                (1)

(Civil service - Contract staff - Frontex staff - Annual leave - Articles 56a and 57 of the Staff Regulations - Shift work - Deduction of days of leave - Equal treatment)
(C/2025/5843)
Language of the case: Italian

Parties


Applicant: Johan Lami (Pescara, Italy) (represented by: F. Bello, A. Bonanni Caione, F. D’Onofrio and G. Borrelli, lawyers)

Defendant: European Border and Coast Guard Agency (represented by: C. Carroll and R.-A. Popa, acting as Agents, and by B. Wägenbaur, lawyer)

Subject

By his action under Article 270 TFEU, the applicant seeks, in essence, annulment of the email of 8 November 2023 and of the decisions of 22 January and 14 February 2024 of the European Border and Coast Guard Agency (Frontex), a declaration that Frontex has infringed the rules applicable to leave entitlement and an order that Frontex return to him the number of days of leave unlawfully deducted from him.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Mr Johan Lami to pay the costs.






(1)  
            OJ C, C/2025/88 of 6.1.2025.


ELI: http://data.europa.eu/eli/C/2025/5843/oj
ISSN 1977-091X (electronic edition)
Case T-351/23: Judgment of the General Court of 24 September 2025 – Kern Pharma v Commission (Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505825EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5825


10.11.2025






Judgment of the General Court of 24 September 2025 – Kern Pharma v Commission


(Case T-351/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation for Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5825)
Language of the case: English

Parties


Applicant: Kern Pharma, SL (Barcelona, Spain) (represented by: K. Roox, T. De Meese, J. Stuyck and C. Dumont, lawyers)

Defendant: European Commission (represented by: E. Mathieu and A. Spina, acting as Agents)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use;










2.


Dismisses the action as to the remainder;










3.


Orders the European Commission, in addition to bearing its own costs, to pay the costs incurred by Kern Pharma, SL;










4.


Declares that Biogen Netherlands BV is to bear its own costs.






(1)  
            OJ C 286, 14.8.2023.


ELI: http://data.europa.eu/eli/C/2025/5825/oj
ISSN 1977-091X (electronic edition)
Case T-409/24: Judgment of the General Court of 24 September 2025 – Al-Aqeelah Takaful Insurance Company v Council (Common foreign and security policy – Restrictive measures adopted against Syria – Freezing of funds – List of persons, entities and bodies subject to the freezing of funds and economic resources – Maintenance of the applicant’s name on the list – Action for annulment – Time limit for bringing proceedings – Partial inadmissibility – Obligation to state reasons – Error of assessment – Right to property – Freedom to conduct a business – Proportionality)
Date: 2025-09-24
Institutions: General Court
Subjects: EU restrictive measure, Syria, economic sanctions, freezing of assets, international sanctions, legal person, principle of proportionality, right to property








C_202505840EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5840


10.11.2025






Judgment of the General Court of 24 September 2025 – Al-Aqeelah Takaful Insurance Company v Council


(Case T-409/24)
                (1)

(Common foreign and security policy - Restrictive measures adopted against Syria - Freezing of funds - List of persons, entities and bodies subject to the freezing of funds and economic resources - Maintenance of the applicant’s name on the list - Action for annulment - Time limit for bringing proceedings - Partial inadmissibility - Obligation to state reasons - Error of assessment - Right to property - Freedom to conduct a business - Proportionality)
(C/2025/5840)
Language of the case: English

Parties


Applicant: Al-Aqeelah Takaful Insurance Company (Damascus, Syria) (represented by: J. Fermon, lawyer)

Defendant: Council of the European Union (represented by: E. Nadbath and D. Laurent, acting as Agents)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment of Council Decision 2013/255/CFSP of 31 May 2013 concerning restrictive measures against Syria (OJ 2013 L 147, p. 14), Council Regulation (EU) No 36/2012 of 18 January 2012 concerning restrictive measures in view of the situation in Syria and repealing Regulation (EU) No 442/2011 (OJ 2012 L 16, p. 1), Council Decision (CFSP) 2024/1510 of 27 May 2024 amending Decision 2013/255 (OJ L, 2024/1510) and Council Implementing Regulation (EU) 2024/1517 of 27 May 2024 implementing Regulation No 36/2012 (OJ L, 2024/1517), in so far as they concern it.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Al-Aqeelah Takaful Insurance Company to bear its own costs and to pay those incurred by the Council of the European Union.






(1)  
            OJ C, C/2024/5507, 23.9.2024.


ELI: http://data.europa.eu/eli/C/2025/5840/oj
ISSN 1977-091X (electronic edition)
Case T-31/24: Judgment of the General Court of 24 September 2025 – Barry’s Bootcamp v EUIPO – Hummel (Device of two chevrons pointing to the right) (EU trade mark – Revocation proceedings – International registration designating the European Union – Figurative mark representing two chevrons pointing to the right – Genuine use of the mark – Article 18(1)(a) and Article 58(1)(a) of Regulation (EU) 2017/1001 – Nature of use of the mark – Form differing in elements that do not alter the distinctive character of the mark)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, footwear industry, registered trade mark, sports equipment, trade-mark law








C_202505830EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5830


10.11.2025






Judgment of the General Court of 24 September 2025 – Barry’s Bootcamp v EUIPO – Hummel (Device of two chevrons pointing to the right)


(Case T-31/24)
                (1)

(EU trade mark - Revocation proceedings - International registration designating the European Union - Figurative mark representing two chevrons pointing to the right - Genuine use of the mark - Article 18(1)(a) and Article 58(1)(a) of Regulation (EU) 2017/1001 - Nature of use of the mark - Form differing in elements that do not alter the distinctive character of the mark)
(C/2025/5830)
Language of the case: English

Parties


Applicant: Barry’s Bootcamp Holdings LLC (Miami, Florida, United States) (represented by: M. Hawkins, T. Dolde and C. Zimmer, lawyers)

Defendant: European Union Intellectual Property Office (represented by: R. Raponi, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Hummel Holding A/S (Aarhus, Denmark) (represented by: T. Bösling and I. George, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 7 November 2023 (Case R 1424/2022-2).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Barry’s Bootcamp Holdings LLC to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO);










3.


Orders Hummel Holding A/S to bear its own costs.






(1)  
            OJ C, C/2024/1878, 11.3.2024.


ELI: http://data.europa.eu/eli/C/2025/5830/oj
ISSN 1977-091X (electronic edition)
Removal from the register: Order of the President of the Court of Justice of 24 September 2025 (requests for a preliminary ruling from the Corte d’appello di Roma – Italy) – Questura di Roma v EJ and Others (Joined Cases C-80/25 to C-87/25, Varpigo and Others)
Date: 2025-09-24
Institutions: Court of Justice
Subjects: asylum seeker, foreign national, fundamental rights, international protection, right of asylum, right to an effective remedy








C_202600077EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/77


5.1.2026






Order of the President of the Court of Justice of 24 September 2025 (requests for a preliminary ruling from the Corte d’appello di Roma – Italy) – Questura di Roma v EJ and Others


(Joined Cases C-80/25 to C-87/25,
                (1)
Varpigo and Others
                (2)
)



(Removal from the register)


(C/2026/77)
Language of the case: Italian

Referring court

Corte d’appello di Roma

Parties to the main proceedings


Applicant: Questura di Roma

Defendants: EJ, PG, VT, OE, BO, LA, AN, DH

Operative part

Joined cases C-80/25 to C-87/25 are removed from the Register of the Court.


(1)  Date lodged: 3.2.2025.

(2)  The name of the present case is a fictitious name. It does not correspond to the real name of any party to the proceedings.


ELI: http://data.europa.eu/eli/C/2026/77/oj
ISSN 1977-091X (electronic edition)
Case T-301/24: Judgment of the General Court of 24 September 2025 – Rústicas del Guadalquivir v EUIPO – Fall Creek Farm and Nursery and Fall Creek Farm & Nursery Europe (SEQUOÏA) (EU trade mark – Revocation proceedings – EU word mark SEQUOÏA – Lack of genuine use – Article 58(1)(a) of Regulation (EU) 2017/1001 – Nature of use)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, fresh fruit, fresh vegetable, registered trade mark, trade-mark law








C_202505836EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5836


10.11.2025






Judgment of the General Court of 24 September 2025 – Rústicas del Guadalquivir v EUIPO – Fall Creek Farm and Nursery and Fall Creek Farm & Nursery Europe (SEQUOÏA)


(Case T-301/24)
                (1)

(EU trade mark - Revocation proceedings - EU word mark SEQUOÏA - Lack of genuine use - Article 58(1)(a) of Regulation (EU) 2017/1001 - Nature of use)
(C/2025/5836)
Language of the case: English

Parties


Applicant: Rústicas del Guadalquivir SL (San José de la Rinconada, Spain) (represented by: C. Casas Feu, J. Dorado López-Lozano and M. González Rodríguez, lawyers)

Defendant: European Union Intellectual Property Office (represented by: T. Frydendahl, acting as Agent)

Other parties to the proceedings before the Board of Appeal of EUIPO, interveners before the General Court: Fall Creek Farm and Nursery, Inc. (Lowell, Massachusetts, United States), Fall Creek Farm & Nursery Europe SRL (Aznalcázar, Spain) (represented by: S. Martínez-Almeida y Alejos-Pita and M. Corbal San Adrián, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment and alteration of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 30 April 2024 (Case R 1606/2023-4).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Rústicas del Guadalquivir SL to pay the costs.






(1)  
            OJ C, C/2024/4603, 29.7.2024.


ELI: http://data.europa.eu/eli/C/2025/5836/oj
ISSN 1977-091X (electronic edition)
Prior notification of a concentration (Case M.11939 – FRIESLANDCAMPINA / MILCOBEL)
Date: 2025-09-24
Institutions: Directorate-General for Competition, European Commission
Subjects: Belgium, France, Germany, Netherlands, agricultural cooperative, dairy industry, dairy production, economic concentration, merger control, milk product








C_202505166EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5166


24.9.2025






Prior notification of a concentration
(Case M.11939 – FRIESLANDCAMPINA / MILCOBEL)
(Text with EEA relevance)
(C/2025/5166)


1.   
On 17 September 2025, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Zuivelcoöperatie FrieslandCampina U.A. (‘FrieslandCampina’, The Netherlands),










—


Milcobel CV (‘Milcobel’, Belgium).




FrieslandCampina and Milcobel will enter into a full merger within the meaning of Article 3(1)(a) of the Merger Regulation.


2.   
The business activities of the undertakings concerned are the following:






—


FrieslandCampina is a Dutch dairy cooperative consisting of around 14 000 dairy farmers in the Netherlands, Germany and Belgium. FrieslandCampina supplies consumer products, such as milk, yoghurt, cheese, infant nutrition and desserts, products for the professional market, such as cream and butter products, ingredients and semi-finished products for producers of infant nutrition, the food industry and the pharmaceutical sector,










—


Milcobel is a Belgian dairy cooperative company consisting of around 1 400 dairy farmers in Belgium, France and the Netherlands. Milcobel forms a multinational company which develops, produces and sells a range of dairy products for consumers and ingredients for professional and industrial customers worldwide.






3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.



4.   
The Commission invites interested third parties to submit their possible observations on the proposed concentration to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11939 – FRIESLANDCAMPINA / MILCOBEL
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  
            OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).


ELI: http://data.europa.eu/eli/C/2025/5166/oj
ISSN 1977-091X (electronic edition)
Case T-393/23: Judgment of the General Court of 24 September 2025 – Teva v Commission (Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU)
Date: 2025-09-24
Institutions: General Court
Subjects: disease of the nervous system, drug surveillance, market approval, medicinal product








C_202505827EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5827


10.11.2025






Judgment of the General Court of 24 September 2025 – Teva v Commission


(Case T-393/23)
                (1)

(Medicinal products for human use - Variation of the marketing authorisation for Tecfidera - Dimethyl fumarate, a medicinal product for human use - Directive 2001/83/EC - Article 14(11) of Regulation (EC) No 726/2004 - Article 266 TFEU)
(C/2025/5827)
Language of the case: English

Parties


Applicant: Teva GmbH (Ulm, Germany) (represented by: Z. West, Solicitor, S. Love, Barrister-at-Law, and G. Morgan, Solicitor)

Defendant: European Commission (represented by: E. Mathieu and A. Spina, acting as Agents)

Intervener in support of the defendant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use.

Operative part of the judgment

The Court:






1.


Annuls Commission Implementing Decision C(2023) 3067 (final) of 2 May 2023 amending the marketing authorisation granted by Decision C(2014) 601 (final) for ‘Tecfidera – Dimethyl fumarate’, a medicinal product for human use;










2.


Dismisses the action as to the remainder;










3.


Orders the European Commission, in addition to bearing its own costs, to pay the costs incurred by Teva GmbH, including those relating to the interim proceedings;










4.


Declares that Biogen Netherlands BV is to bear its own costs.






(1)  
            OJ C 321, 11.9.2023.


ELI: http://data.europa.eu/eli/C/2025/5827/oj
ISSN 1977-091X (electronic edition)
Case T-390/23: Judgment of the General Court of 24 September 2025 – Barry’s Bootcamp v EUIPO – Hummel (Device of two horizontal black chevrons) (EU trade mark – Revocation proceedings – EU figurative mark representing two horizontal black chevrons – Action for annulment – Time limits for instituting proceedings – Admissibility – Genuine use of the mark – Article 18(1)(a) and Article 58(1)(a) of Regulation (EU) 2017/1001 – Nature of use of the mark – Form differing in elements that do not alter the distinctive character of the mark – Obligation to state reasons – Article 94(1) of Regulation 2017/1001)
Date: 2025-09-24
Institutions: General Court
Subjects: EU trade mark, clothing, footwear industry, registered trade mark, sports equipment, trade-mark law








C_202505826EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/5826


10.11.2025






Judgment of the General Court of 24 September 2025 – Barry’s Bootcamp v EUIPO – Hummel (Device of two horizontal black chevrons)


(Case T-390/23)
                (1)

(EU trade mark - Revocation proceedings - EU figurative mark representing two horizontal black chevrons - Action for annulment - Time limits for instituting proceedings - Admissibility - Genuine use of the mark - Article 18(1)(a) and Article 58(1)(a) of Regulation (EU) 2017/1001 - Nature of use of the mark - Form differing in elements that do not alter the distinctive character of the mark - Obligation to state reasons - Article 94(1) of Regulation 2017/1001)
(C/2025/5826)
Language of the case: English

Parties


Applicant: Barry’s Bootcamp Holdings LLC (Miami, Florida, United States) (represented by: M. Hawkins, T. Dolde and C. Zimmer, lawyers)

Defendant: European Union Intellectual Property Office (represented by: R. Raponi, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Hummel Holding A/S (Aarhus, Denmark) (represented by: S. Pedersen, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 5 April 2023 (Case R 1423/2022-2).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Barry’s Bootcamp Holdings LLC to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO);










3.


Orders Hummel Holding A/S to bear its own costs.






(1)  
            OJ C 314, 4.9.2023.


ELI: http://data.europa.eu/eli/C/2025/5826/oj
ISSN 1977-091X (electronic edition)